LXU LSB INDUSTRIES, INC.
Industrial Inorganic Chemicals · NYSE · SEC CIK 60714 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY13.0%
TTM net income YoY6,982.5%
TTM EPS YoY6,400.0%
Revenue 3-yr CAGR-1.6%
Net income 3-yr CAGR-22.6%
Margins
Gross margin19.9%
Operating margin11.2%
Net margin7.0%
FCF margin9.7%
EBITDA margin24.3%
Returns
ROE8.7%
ROA3.9%
ROIC (approx.)6.9%
Asset turnover0.56x
Leverage & solvency
Liabilities / assets54.4%
Debt / equity0.79x
Current ratio3.01x
Interest coverage2.61x
Cash quality & payout
Operating cash flow / net income3.25x
Accruals ratio-8.7%
Payout ratio—
Capex / revenue12.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $615.21M | $522.40M |
| Cost of revenue | $510.91M | $474.60M |
| Gross profit | $104.30M | $47.80M |
| SG&A expense | $41.51M | $41.77M |
| Operating income | $57.27M | -$5.50M |
| Interest expense | $30.66M | $34.45M |
| Pretax income | $32.55M | -$26.04M |
| Income tax | $7.94M | -$6.68M |
| Net income | $24.61M | -$19.35M |
| EBITDA | $139.20M | $68.97M |
| EPS (basic) | 0.34 | -0.27 |
| EPS (diluted) | 0.34 | -0.27 |
| Weighted avg. shares (diluted) | 72.36M | 71.97M |
| Balance sheet | ||
| Cash & equivalents | $19.51M | $20.23M |
| Short-term investments | $128.96M | $163.97M |
| Receivables | $57.21M | $38.76M |
| Inventory | $18.31M | $24.90M |
| Current assets | $293.29M | $309.71M |
| PP&E, net | $833.52M | $847.57M |
| Total assets | $1.17B | $1.19B |
| Current liabilities | $105.51M | $135.63M |
| Short-term debt | $760,000 | $9.12M |
| Long-term debt | $440.30M | $476.16M |
| Total debt | $441.06M | $485.28M |
| Total liabilities | $653.57M | $695.55M |
| Shareholders' equity | $519.97M | $491.64M |
| Net debt | $421.54M | $465.05M |
| Cash flow statement | ||
| Operating cash flow | $95.52M | $86.58M |
| Capital expenditure | $77.46M | $92.29M |
| Free cash flow | $18.06M | -$5.72M |
| Investing cash flow | -$42.36M | -$53.08M |
| Financing cash flow | -$53.88M | -$114.30M |
| Depreciation & amortization | $81.93M | $74.48M |
| Stock-based compensation | $7.37M | $6.61M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.